ArticleBirth (Berkeley, Calif.)2025
The Cost of Untreated Perinatal Mood and Anxiety Disorders (PMADs) in Montana: An Economic Analysis of Perinatal Mental Health in a Rural State.
Article in Birth (Berkeley, Calif.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cost-effectiveness of virtual Mindfulness-Based Cognitive Therapy on pregnancies at high risk of perinatal depression.Pregnancy (Hoboken, N.J.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundAlthough extremely common, and with a broad range of associated negative outcomes for both parents and infants, the full impact and cost of perinatal mood and anxiety disorders (PMADs) is under-researched. Rural states, such as Montana, in particular experience gaps in access to mental healthcare and high rates of PMADs, emphasizing a need for an economic analysis of untreated PMADs. To address this gap, a cost analysis of the impact of untreated PMADs in Montana was conducted using 2021 birth data.
methodsA cost-of-illness analysis was conducted to estimate the incremental costs of untreated PMADs in Montana. Secondary data sources and peer-reviewed literature were utilized to provide baseline estimates of the prevalence of maternal and birth outcomes in Montana and to estimate the impact of PMADs on these outcomes from the perinatal period through the first year postpartum.
resultsUsing 15% as the PMAD prevalence rate in Montana, the total estimated incremental cost of untreated perinatal mood and anxiety disorders for births in 2021 is about $21.7 million. This is about $12,897 per impacted mother-child pair. DISCUSSION: This study provides needed insight into the economic impact of untreated PMADs and highlights the broad range of negative impacts PMADs have on the well-being of parents and infants. This study highlights the importance of providing effective treatment to people experiencing PMADs to improve the health of both parents and their infants and has important policy implications for increased funding and workforce development for the detection and treatment of PMADs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.